Pharmafile Logo
Pharmafocus logo
Advanced Search
trummy

Trump moves to formally remove the US from the World Health Organization

July 8, 2020
Research and Development COVID-19, Trump, WHO

President Donald Trump has formally moved to end the US membership of the World Health Organization. He has notified both …

News
brazil

Brazilian President Jair Bolsonaro tests positive for COVID-19, says he is taking hydroxychloroquine

July 8, 2020
Research and Development Brazil, COVID-19, President of Brazil

Jair Bolsonaro, the President of Brazil, has tested positive for COVID-19 and says he treating the virus with hydroxychloroquine. The …

News
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

July 8, 2020
Research and Development

Coronavirus lockdowns and immunity feature in the news this week, with the UK Government accused of withholding Pillar 2 COVID-19 …

News
shutter

UK universities join forces for early-stage COVID-19 therapy testing platform

July 7, 2020
Manufacturing and Production, Research and Development COVID-19, UK, coronavirus

A coalition of UK universities have come together to build a new clinical trial and drug testing platform to evaluate …

News
who_flag

Scientists urge World Health Organization to reconsider stance on COVID-19 airborne spread

July 7, 2020
Manufacturing and Production COVID-19, WHO, coronavirusm

239 scientists from over 30 countries are urging the World Health Organization to put more focus on assessing the possible …

News
china-pharmaceutical-industry

Emergent forges five-year partnership to produce one billion doses of Janssen’s COVID-19 vaccine

July 7, 2020
Manufacturing and Production COVID-19, Emergent, J&J, JJ, Janssen, coronavirus

As many pharma firms move to secure upscaled manufacturing capacity for their potential COVID-19 vaccines, Johnson & Johnson’s Janssen has …

News
johnsonsss

Johnson & Johnson cuts price of anti-TB medicine in poorer countries

July 7, 2020
Manufacturing and Production J&J, JJ, TB

Johnson & Johnson have announced that it will cut the price of its tuberculosis drug Bedaquiline, sold under the brand …

News
purdue

Jonathan Sackler, co-owner of Purdue Pharma, dies from cancer

July 7, 2020
Manufacturing and Production Purdue, opioid, opioid crisis

Jonathan Sackler, son of Purdue Pharma founder Raymond Sackler, died on 30 June from cancer, according to the company. He …

News
3018710552_f8cebf1dab_c

Tesla to offer “microfactories” to scale up production of CureVac’s potential COVID-19 vaccine

July 6, 2020
Manufacturing and Production, Sales and Marketing COVID-19, CureVac, Vaccine, tesla

Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly …

News
viiv

ViiV Healthcare secures FDA approval for Rukobia combo in multidrug-resistant HIV-1

July 6, 2020
Sales and Marketing FDA, HIV, ViiV Healthcare

ViiV Healthcare, the HIV specialist majority owned by GSK which also counts Shionogi and Pfizer among its shareholders, has secured …

News
remsssy

US moving remdesivir supplies to COVID-19 hotspots

July 6, 2020
Sales and Marketing Arizona, COVID, states, texas

The US government is sending significant remdesivir supplies to states that are being hit hardest by the coronavirus. Florida, Arizona …

News
amoeba

Florida issues warning over ‘brain-eating’ amoeba

July 6, 2020
Sales and Marketing amoeba, infection, lakes

The Florida Department of Health has issued a warning over a rare case of ‘brain-eating’ amoeba after one person has …

News
who_flag

WHO halt coronavirus trials of hydroxychloroquine, lopinavir and ritonavir

July 6, 2020
Sales and Marketing COVID, COVID-19, WHO, coronavirus

The World Health Organization has discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments. This was …

News
european_commission_web

Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients

July 3, 2020
Medical Communications, Research and Development Europe, Mundipharma, invokana

European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium glucose co-transporter …

News
racism_protests

US anti-racism protests did not cause spike in coronavirus cases, new study shows

July 3, 2020
Medical Communications COVID-19, coronavirus

Widespread protests against racism and police brutality did not cause a significant spike in coronavirus cases in the US, according …

News
vaccination-1215279_960_720

Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate

July 3, 2020
Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …

News

Texas mandates the wearing of facemasks in public

July 3, 2020
Medical Communications COVID-19, coronavirus

Texas becomes the latest state in the US to mandate the wearing of facemasks in public, as COVID-19 cases skyrocket …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …

News
shutterstock_38078521

EUSA Pharma gets FDA green light to evaluate IL-6 inhibitor siltuximab in COVID-19 patients

July 2, 2020
Research and Development COVID-19, Eusa Pharma, siltuximab

Efforts push on to discover an effective treatment for COVID-19 in more than 100 different drug candidates worldwide. EUSA Pharma …

News
london-railway-station-travel

COVID-19 immunity may be more widespread than previously thought, new study suggests

July 2, 2020
Business Services coronaviurs, covid-29, herd immunity

Coronavirus immunity in the world’s population may be more widespread than initially thought, even in those who have tested negative …

News
The Gateway to Local Adoption Series

Latest content

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026

European Medicines Agency recommended 104 medicines for approval in 2025

January 20, 2026

Spike in searches relating to spinal muscular atrophy following Jesy Nelson disclosure

January 19, 2026

Biogen’s high-dose Spinraza regimen receives European Commission approval for spinal muscular atrophy

January 19, 2026

Alto Neuroscience announces new patent for depression treatment

January 15, 2026